Sharp Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Sharp Financial Services's PFE Position: Q1 2026 in Review
Sharp Financial Services reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $12.1K and leaving 22,333 shares worth $627K. The position accounts for 0.31% of the portfolio, ranked #44.
Sharp Financial Services first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sharp Financial Services held 22,333 shares of Pfizer worth $627K as of Q1 2026.
- Sharp Financial Services sold 456 Pfizer shares in Q1 2026, an estimated $12.1K.
- Pfizer made up 0.31% of Sharp Financial Services's portfolio in Q1 2026, its #44 holding.
- Sharp Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sharp Financial Services's 13F filing for Q1 2026, filed 27 Apr 2026.